PatchSiren cyber security CVE debrief
CVE-2026-65084 NVIDIA CVE debrief
NVIDIA NemoClaw for Linux contains a vulnerability in its deployment process, allowing for improper certificate validation. This could lead to information disclosure, data tampering, code execution, and escalation of privileges. The vulnerability is tracked under CVE-2026-65084 and has been assessed as HIGH severity with a CVSS score of 8.1. Affected systems may require immediate attention to ensure proper certificate validation and mitigate potential risks. Organizations should verify their deployment configurations and review incident response plans.
- Vendor
- NVIDIA
- Product
- NemoClaw
- CVSS
- HIGH 8.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-08-25
- Original CVE updated
- 2026-09-01
- Advisory published
- 2026-08-25
- Advisory updated
- 2026-09-01
Who should care
Organizations using NVIDIA NemoClaw for Linux, Linux administrators, and security teams responsible for managing and securing Linux deployments should be aware of this vulnerability. They should verify their deployment configurations and ensure proper certificate validation to mitigate potential risks associated with this vulnerability. Additionally, they should review and update incident response plans to address potential exploitation of this vulnerability and implement additional monitoring for potential certificate validation issues.
Technical summary
NVIDIA NemoClaw for Linux contains a vulnerability in its deployment process, where an attacker could cause improper certificate validation. A successful exploit of this vulnerability might lead to information disclosure, data tampering, code execution, and escalation of privileges. The vulnerability is tracked under CVE-2026-65084 and has been assessed as HIGH severity with a CVSS score of 8.1. Affected systems may require immediate attention to ensure proper certificate validation and mitigate potential risks.
Defensive priority
Organizations using NVIDIA NemoClaw for Linux should verify their deployment configurations and ensure proper certificate validation to mitigate potential risks.
Recommended defensive actions
- Verify NVIDIA NemoClaw for Linux deployment configurations for proper certificate validation.
- Implement additional monitoring for potential certificate validation issues.
- Review and update incident response plans to address potential exploitation of this vulnerability.
- Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up.
- Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
- Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.
- Check relevant monitoring, detection, and logs for exposed assets that need extra review.
Evidence notes
The CVE record indicates a vulnerability in NVIDIA NemoClaw for Linux, allowing for improper certificate validation, which could lead to information disclosure, data tampering, code execution, and escalation of privileges. However, detailed information about affected versions and specific attack vectors is limited. Further verification is needed to understand the full scope of the vulnerability and potential impacts on Linux deployments.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-65084 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-65084
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-65084 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-65084
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://github.com/NVIDIA/product-security/tree/main/2026/5872
[email protected] - Patch
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.